Concepedia

Maria-Carmen Fernandez

MF

Statistics

Publications

3

Citations

94

H-Index

3

Active since

2006

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (Spain)

Maria-Carmen Fernandez is an author at Eli Lilly (United States) specializing in pharmacology, natural sciences, and drug discovery.

Top concepts

Publications per year

2006–2017

3

Publications

3

Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

Genshi Zhao, Colin F. Green, Yu‐Hua Hui et al. · Molecular Cancer Therapeutics · 2017 · 45 citations

Design, synthesis and structure–activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors

Maria-Carmen Fernandez, Ana Escribano, Ana Mateo et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations · Full text

, , +2

A novel class of AMPA receptor allosteric modulators. Part 1: Design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives

Maria-Carmen Fernandez, Ana M. Castaño‐León, Esteban Domı́nguez et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 21 citations · Full text

, , +8

1–3 of 3